Showing posts with label cancer patients. Show all posts
Showing posts with label cancer patients. Show all posts

Wednesday, 27 August 2025

Approach to Cope with Cancer Treatment: I Will Rise Again- Our Voices Must be Heard | Book Publisher International

 

The current book is specifically designed for cancer patients, prioritizing their needs over the scientific community. Its significance lies in motivating patients during their illness and actively improving their quality of life. Serving as a comprehensive guide, it addresses the reality of cancer patients and explores how their experiences ripple through the lives of those around them family, friends, and medical professionals. The book's methodology combines patient questionnaires and interviews, effectively bridging the gap between academic research and emotional support. By intertwining scientific insights with personal stories, it offers a holistic perspective on cancer management. From multiple feelings in the hard time of diagnosis, and chemotherapy regimens to dietary adjustments and spiritual well-being, the book provides practical advice for enhancing patients' lives. While its primary audience remains patients themselves, it also benefits the scientific community, particularly in oncology and psycho-oncology. Through intimate narratives and interviews, it offers emotional support and enriches the existing literature on cancer care. This holistic approach enhances healthcare professionals' understanding of patients' experiences, promoting compassionate and personalized care. Additionally, the book serves as an educational tool, unravelling the emotional and practical dynamics of the cancer journey. The book is thoughtfully organized, and the book caters to both scholarly readers and the general public interested in oncological challenges and patient care.

Author(s) Details

Dr. Asmaa F. Hamouda

Alexandria University, Egypt.

 

Please see the link:- https://doi.org/10.9734/bpi/mono/978-81-976377-4-2

 

Friday, 25 November 2022

Investigating the Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary| Chapter 4 | Current Innovations in Medicine and Medical Science Vol. 8

 Nutrition is an basic facts of lifestyle and has an undeniable affect health and disease stop, including tumor. The incidence of cancer is growing worldwide and in addition to swelling related diseases, a important number of them maybe prevented by a suitable behavior.Methyl-donors are part of the food as micronutrients and have important roles in metabolic processes and DNA methylation through their partnership in one-element cycles. Their appropriate level in the human body is main to stabilize a healthy metabolic balance and their inadequacy can lead to several syndromes and diseases and has happened also implicated in the asperity of SARS-CoV-2 (COVID-19) infection. Nutrition therapy has before been recognized as an appropriate form in the management of malignancy-related fatigue as part of character of life.Breast cancer is a heterogenous ailment and classified into subtypes basically for one expression of estrogen receptor, progesterone receptor and human epidermal growth determinant receptor 2. The estrogen and progesterone receptor negative tumors are suggested expected more sensitive to non-hormonal factors contained nutrition. Colorectal cancer has a complex study of animal with risk factors of two together genetic and tangible origin, including corpulence and alcohol consumption. Based on the organic behaviour pancreatic cancer is an aggressive carcinoma with remote possibility where risk factors still include such behavior factors as alcohol and hot which cause intrinsic inflammation and promote lump progression.In this study, we aimed to survey the potential protective effect of methyl-donor consumption in breast, colorectal and pancreatic tumor by following up patients. We erect that around the recommended often intake of methyl-donors (RDAs: methionine 1140mg/60kg, B6 1.3-2mg, B9 0.4mg) was persuasive in supporting the overall survival of conscience and colorectal cancer subjects. Additionally, a relatively higher amount was effective in pancreatic adenocarcinoma patients possibly in accordance with the known poor assimilation of vitamins in the small intestine in this place type cancer. Smoking habit considerably and negatively correlated accompanying the total intake of methyl-donors in pancreatic malignancy patients, additionally, in colorectal cancer patients the folate in addition to betaine intake significantly and absolutely correlated with IL-8 cytokine level.Our results plan that appropriate methyl-donor consumption may be an appropriate accessory of normal oncotherapy which may enhance improve quality of history. Its support of cancer stop and patients' survival needs further proof in large patient cohorts.

Author(s) Details:

Eva Kiss,
1st Department of Internal Medicine and Oncology, Oncology Profile, Semmelweis University, 1083 Budapest, Koranyi S. u 2/a, Hungary.

Anett Hajdu,
1st Department of Internal Medicine and Oncology, Oncology Profile, Semmelweis University, 1083 Budapest, Koranyi S. u 2/a, Hungary.

Gertrud Forika,
1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Ulloi u. 26, Hungary.

Magdolna Dank,
1st Department of Internal Medicine and Oncology, Oncology Profile, Semmelweis University, 1083 Budapest, Koranyi S. u 2/a, Hungary.

Tibor Krenacs,
1st Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Ulloi u. 26, Hungary.

Zsuzsanna Nemeth,
1st Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Koranyi S. u 2/a, Hungary.

Please see the link here: https://stm.bookpi.org/CIMMS-V8/article/view/8721